• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动激活的肝自噬联合水飞蓟素与抑制地塞米松诱导的脂肪肝损伤大鼠细胞凋亡有关。

Exercise-activated hepatic autophagy combined with silymarin is associated with suppression of apoptosis in rats subjected to dexamethasone induced- fatty liver damage.

机构信息

Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Department of Exercise Physiology, Faculty of Sports Sciences, University of Mazandaran, Mazandaran, Iran.

出版信息

Mol Biol Rep. 2024 Aug 22;51(1):928. doi: 10.1007/s11033-024-09844-4.

DOI:10.1007/s11033-024-09844-4
PMID:39172304
Abstract

AIM

There is a need for effective treatments for non-alcoholic fatty liver disease (NAFLD) that are economically inexpensive, and have few side effects. The present study aimed to investigate exercise training and silymarin on hepatocyte death factors in rats with liver damage.

METHODS

Forty-nine male Wistar rats were assigned to seven groups: sedentary control, fatty liver control (DEX), fatty liver + high-intensity interval training (HIIT), fatty liver + HIIT + silymarin (HIIT + SILY), fatty liver + continuous training (CT), fatty liver + CT + silymarin (CT + SILY), and fatty liver + silymarin (SILY). A subcutaneous injection of dexamethasone for 7 days was used to induce fatty liver in rats. Masson's trichrome and hematoxylin-eosin staining were done to evaluate hepatic injury. The hepatocyte apoptosis was determined by TUNEL assay. Real-Time PCR was conducted to evaluate the gene expressions of caspase-9, adenosine monophosphate-activated protein kinase (AMPKα1), mitofusin 2 (Mfn2), and damage-regulated autophagy modulator (DRAM). Liver tissue changes and serum levels of liver enzymes were also evaluated.

RESULTS

Liver apoptosis was decreased in the CT, HIIT, HIIT + SILY and CT + SILY groups compared to the DEX group. Both continuous and high-intensity training models produced beneficial alterations in liver morphology and hepatic injuries that were significant in exercise training + silymarin group. This impact was accompanied by increased AMPKα1 and DRAM gene expression and decreased caspase-9 and Mfn2 gene expression. Liver enzyme levels were high in the DEX group and treatment with silymarin significantly reduced it.

CONCLUSION

Silymarin supplementation combined with interval or continuous training substantially improves DEX-induced hepatic steatosis and hepatocyte injury mostly through suppressing liver apoptosis and upregulating autophagy, which may provide a novel perspective for NAFLD treatment.

摘要

目的

需要寻找一种有效、经济实惠且副作用小的非酒精性脂肪性肝病(NAFLD)治疗方法。本研究旨在探讨运动训练和水飞蓟素对肝损伤大鼠肝细胞死亡因子的影响。

方法

将 49 只雄性 Wistar 大鼠分为 7 组:安静对照组、脂肪肝对照组(DEX)、脂肪肝+高强度间歇训练组(HIIT)、脂肪肝+HIIT+水飞蓟素组(HIIT+SILY)、脂肪肝+持续训练组(CT)、脂肪肝+CT+水飞蓟素组(CT+SILY)和脂肪肝+水飞蓟素组(SILY)。通过皮下注射地塞米松 7 天诱导大鼠脂肪肝。采用 Masson 三色和苏木精-伊红染色评估肝损伤,TUNEL 法检测肝细胞凋亡,实时 PCR 检测半胱氨酸天冬氨酸蛋白酶-9(caspase-9)、腺苷单磷酸激活蛋白激酶(AMPKα1)、线粒体融合蛋白 2(Mfn2)和损伤调节自噬调节剂(DRAM)的基因表达。还评估了肝组织变化和血清肝酶水平。

结果

与 DEX 组相比,CT、HIIT、HIIT+SILY 和 CT+SILY 组的肝凋亡减少。连续和高强度训练模型均对肝形态和肝损伤产生有益的改变,在运动训练+水飞蓟素组中更为显著。这种影响伴随着 AMPKα1 和 DRAM 基因表达的增加以及 caspase-9 和 Mfn2 基因表达的减少。DEX 组的肝酶水平较高,水飞蓟素治疗显著降低了其水平。

结论

水飞蓟素补充剂联合间歇或持续训练可显著改善 DEX 诱导的肝脂肪变性和肝细胞损伤,主要通过抑制肝凋亡和上调自噬来实现,这为 NAFLD 的治疗提供了新的视角。

相似文献

1
Exercise-activated hepatic autophagy combined with silymarin is associated with suppression of apoptosis in rats subjected to dexamethasone induced- fatty liver damage.运动激活的肝自噬联合水飞蓟素与抑制地塞米松诱导的脂肪肝损伤大鼠细胞凋亡有关。
Mol Biol Rep. 2024 Aug 22;51(1):928. doi: 10.1007/s11033-024-09844-4.
2
Synergistic salvation: HIIT and herbal allies reverse NAFLD damage in rats.协同拯救:高强度间歇训练与草本辅助物逆转大鼠非酒精性脂肪性肝病损伤
J Mol Histol. 2025 Apr 5;56(2):131. doi: 10.1007/s10735-025-10413-7.
3
Pharmacological Activation of AMPK Prevents Drp1-mediated Mitochondrial Fission and Alleviates Hepatic Steatosis .AMPK 的药理学激活可防止 Drp1 介导线粒体裂变并减轻肝脂肪变性。
Curr Mol Med. 2024;24(12):1506-1517. doi: 10.2174/0115665240275594231229121030.
4
Oxymatrine relieves non-alcoholic fatty liver disease by promoting sirtuin 1/adenosine 5'-monophosphate-activated protein kinase pathway and peroxisome proliferator activated receptor alpha-mediated hepatic fatty acid oxidation.氧化苦参碱通过促进沉默调节蛋白1/5'-单磷酸腺苷激活的蛋白激酶途径和过氧化物酶体增殖物激活受体α介导的肝脏脂肪酸氧化来缓解非酒精性脂肪性肝病。
Eur J Pharmacol. 2025 Jan 15;987:177173. doi: 10.1016/j.ejphar.2024.177173. Epub 2024 Dec 3.
5
Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.高强度运动可改善肝脏炎症和 NASH 的进展。
Mol Metab. 2021 Nov;53:101270. doi: 10.1016/j.molmet.2021.101270. Epub 2021 Jun 10.
6
L-carnitine attenuates autophagic flux, apoptosis, and necroptosis in rats with dexamethasone-induced non-alcoholic steatohepatitis.左旋肉碱减轻地塞米松诱导的大鼠非酒精性脂肪性肝炎中的自噬通量、细胞凋亡和坏死性凋亡。
BMC Pharmacol Toxicol. 2024 Dec 30;25(1):102. doi: 10.1186/s40360-024-00820-z.
7
Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.丰加霉素可减轻游离脂肪酸诱导的培养肝细胞中的肝脂肪变性和细胞凋亡,并改善小鼠的非酒精性脂肪性肝病。
PLoS One. 2017 Mar 9;12(3):e0170591. doi: 10.1371/journal.pone.0170591. eCollection 2017.
8
Saroglitazar mitigated NASH-associated hepatic injury in dexamethasone-treated rats via modulating autophagy, apoptosis, and necroptosis.沙格列汀通过调节自噬、凋亡和坏死性凋亡减轻地塞米松诱导的大鼠非酒精性脂肪性肝炎相关肝损伤。
Toxicol Appl Pharmacol. 2024 Jan;482:116774. doi: 10.1016/j.taap.2023.116774. Epub 2023 Nov 30.
9
Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease.白藜芦醇联合连续和间歇运动对非酒精性脂肪性肝病老年大鼠肝脏细胞凋亡、氧化应激和炎症生物标志物的影响。
Arch Physiol Biochem. 2019 May;125(2):142-149. doi: 10.1080/13813455.2018.1441872. Epub 2018 Feb 20.
10
GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.胰高血糖素样肽-1类似物通过AMPK/mTOR途径诱导自噬来改善肝脏脂质积累。
Biochem Biophys Res Commun. 2016 Aug 5;476(4):196-203. doi: 10.1016/j.bbrc.2016.05.086. Epub 2016 May 18.

本文引用的文献

1
Autophagy: Regulator of cell death.自噬:细胞死亡的调控者。
Cell Death Dis. 2023 Oct 4;14(10):648. doi: 10.1038/s41419-023-06154-8.
2
Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms.运动是治疗非酒精性脂肪肝的良药:潜在机制的探索。
Nutrients. 2023 May 24;15(11):2452. doi: 10.3390/nu15112452.
3
Exercise-induced increases in "liver function tests" in a healthy adult male: Is there a knowledge gap in primary care?健康成年男性运动诱导的“肝功能检查”升高:初级保健中是否存在知识差距?
J Family Med Prim Care. 2023 Jan;12(1):177-180. doi: 10.4103/jfmpc.jfmpc_1923_22. Epub 2023 Feb 15.
4
The Link between NAFLD and Metabolic Syndrome.非酒精性脂肪性肝病与代谢综合征之间的联系。
Diagnostics (Basel). 2023 Feb 7;13(4):614. doi: 10.3390/diagnostics13040614.
5
Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD.自噬在非酒精性脂肪性肝病发病机制及发展中的代谢作用
Metabolites. 2023 Jan 7;13(1):101. doi: 10.3390/metabo13010101.
6
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.非酒精性脂肪性肝病(NAFLD)发病机制及天然产物的防治。
Int J Mol Sci. 2022 Dec 7;23(24):15489. doi: 10.3390/ijms232415489.
7
Therapeutic strategies for liver diseases based on redox control systems.基于氧化还原控制系统的肝脏疾病治疗策略。
Biomed Pharmacother. 2022 Dec;156:113764. doi: 10.1016/j.biopha.2022.113764. Epub 2022 Oct 10.
8
Autophagy: A Key Regulator of Homeostasis and Disease: An Overview of Molecular Mechanisms and Modulators.自噬:内稳态和疾病的关键调节者:分子机制和调节剂概述。
Cells. 2022 Jul 22;11(15):2262. doi: 10.3390/cells11152262.
9
Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease.耐力运动介导的代谢重排可减轻高卡路里饮食诱导的非酒精性脂肪肝疾病。
Ann Hepatol. 2022 Jul-Aug;27(4):100709. doi: 10.1016/j.aohep.2022.100709. Epub 2022 Apr 28.
10
Autophagy in major human diseases.自噬在重大人类疾病中的作用。
EMBO J. 2021 Oct 1;40(19):e108863. doi: 10.15252/embj.2021108863. Epub 2021 Aug 30.